We validated lung injury prediction scores (LIPS) in predicting acute respiratory distress syndrome (ARDS) and in-hospital mortality in high-risk major trauma and surgical ICU patients.
Introduction
Despite the recent developments in the management of acute respiratory distress syndrome (ARDS), its mortality rate remains high [1, 2] . Being with limited specific therapeutic options [3] , identifying patients at risk for ARDS is important for searching for prevention strategies [4] . Many scores have been studied for predicting ARDS [5, 6] in several patient categories. The use of these scores in the subgroups of trauma and surgery patients is not well validated.
The exposure to stresses of trauma or surgery rendered those patients an important subgroup who are more liable to ARDS [7] . ARDS occurred in 52.6% of surgical patients [8] and in 12-25% of patients with trauma [1, 9, 10] , with mortality rates as high as 50-80% [11] [12] [13] .
We intended to validate two previously established scores in predicting ARDS and in-hospital mortality in critically ill patients [with acute physiology and chronic health evaluation-II (APACHE-II) score ≥15] with major trauma and/or surgeries.
Patients and methods
We recruited patients admitted to ICU with major surgery and/or trauma and APACHE-II score more than or equal to 15 during the period from January 2016 to May 2017 in this prospective observational study. We excluded from the study patients diagnosed to have ARDS on admission, patients who had a history of previous hospital admission within 7 days, patients in whom cardiac cause may explain their hypoxia, and those with age less than 18 years old.
We reported the predisposing conditions of ARDS and hemodynamic parameters including heart rate, systolic blood pressure, and diastolic blood pressure. Dividing the heart rate by the systolic blood pressure represents the shock index [14] . We measured C-reactive protein (CRP) levels on admission (CRP-1) and 2 days later (CRP-2). Lung injury prediction scores (LIPS) were subsequently calculated using two previously studied scores that will be referred in our study as score-1 [5] and score-2 [6] .
The primary and secondary outcomes were the ARDS development and the in-hospital mortality, respectively. ARDS diagnosis was established by two different ICU physicians blinded to score results according to Berlin definition [15] . Patients or firstdegree relatives were consented before enrollment. The study protocol was approved by the institutional review board at Cairo University.
Statistical methods
The study variables were studied in terms of normality. Shapiro-Wilk's test with P value more than 0.05 [16, 17] and z value of skewness and kurtosis between −1.96 and +1.96 [18] were required to consider a variable as normally distributed. Being non-normally distributed, we expressed the continuous variables as median (Q 1 -Q 3 ). Categorical variables were expressed as frequency and proportion. When two groups were studied, nonparametric test (Mann-Whitney U test) was used for quantitative variables and χ 2 test was used for qualitative data. Receiver operator characteristic analysis was performed to define test accuracy. The accuracy of different variables was expressed as area under curve (AUC) for the receiver operator characteristic. The highest Youden's index was used to identify the best cutoff values. The statistical significance was identified at P value less than or equal to 0.05. The software used was the statistical package of social science (IBM Corporation, Released 2013, IBM SPSS Statistics for Windows, Version 22.0, Armonk, NY: IBM Corporation).
Results
We recruited 93 patients in our study. Fourteen patients were excluded later owing to suspected cardiac cause in eight patients and admission by ARDS in six patients. The remaining 79 patients represented the study sample. The demographic data and predisposing conditions are seen in (Table 1) . Thirty-three (41.8%) patients developed ARDS during hospital stay and 46 (58.2%) patients did not develop ARDS. ARDS was developed after 4 (2-7) days. The presence of predisposing conditions in both groups is seen in (Table 1) .
Both LIPS were significant predictors for ARDS development. The score-1 was 5 (4-6) in patients who developed ARDS versus 3 (1.8-4.3) in those who did not develop ARDS (P=0.000) and the score-2 was 4.5 (3-6.3) and 3 (1.5-4.6) in those who developed and did not develop ARDS, respectively (P=0.001). The CRP-1 was 48 (24-48) mg/l in both groups (P=0.96), whereas CRP-2 was 96 (57-192) mg/l and 48 (24-96) mg/l in both groups, respectively (P=0.000) ( Figure 1) . The AUC was 0.741 for score-1, 0.712 for score-2, and 0.740 for CRP-2 ( Figure 2 ). The best cutoff values of the different variables are shown in ( mg/l in nonsurvivors (P=0.000). The AUC for CRP-2 in predicting in-hospital mortality was 0.747. CRP-2 of 94 mg/l was seen to have sensitivity, specificity, positive predictive value, and negative predictive value of 73, 70, 60, and 81%, respectively (Figure 3 ). CRP-2, C-reactive protein level on day 2; NPV, negative predictive value; PPV, positive predictive value.
Figure 2
The ROC curve for score-1, score-2, and CRP-2 in predicting ARDS. ARDS, acute respiratory distress syndrome; CRP, C-reactive protein; ROC, receiver operator characteristic.
Discussion
Surgical and traumatic critically ill patients have different inflammatory pathways rendering them unique pathophysiologic subset of patients with ARDS. Early recognition of those patients at higher risk for ARDS can help in identifying subset of patients who can be included in preventive studies and to modify the strategies of treatment before the disease becomes too severe. Some investigators derived prediction scores for ARDS development in general hospital admissions not specified to surgery and/or trauma patients [5, 6] . The confirmed validity and simplicity of these scores increased their use in predicting patients at risk for ARDS. We intended to validate two previously studied scores [5, 6] in predicting ARDS and in-hospital mortality in critically ill surgical and/or trauma patients.
ARDS developed in 41.8% of our sample. The ARDS incidence was 5.5% in one study [5] and was 17% in the other [6] . Higher incidence of 52.6%, which is closer to ours, was reported by Bauman et al. [8] in surgical critical care patients. Bauman and colleagues speculated this higher incidence to the different ARDS diagnostic criteria. We should also consider the more critically ill patients enrolled in Bauman's study and in our study. They enrolled ventilated patients and we enrolled patients with high APACHE-II, whereas the other studies enrolled all emergency department (ED) patients with one risk factor for ARDS.
We found that both scores are significant predictors for ARDS development. The accuracy of these scores were however not high in predicting ARDS. The AUC was 0.741 for score-1 and 0.712 for score-2. In general ED patients, score-1 [5] and score-2 [6] had higher AUC of 0.85 and 0.84 for predicting ARDS. Bauman et al. [8] found, however, lower AUC of 0.79 when applying the LIPS in surgically ventilated patients. Other authors showed that a surgical lung injury prediction The ROC curve for the scores and CRP-2 in predicting in-hospital mortality. CRP, C-reactive protein; ROC, receiver operator characteristic.
score is a poor ARDS predictor in high-risk surgical patients with AUC of 0.56. They modified this score to a surgical lung injury prediction-2 score, which had an AUC of 0.84 [19] .
In the validation study of score-2, the authors identified a cutoff value of 3 to be 69% sensitive and 84% specific. In trauma and/or surgery patients, we identified a score of 2.25 to be 91% sensitive but with only 41% specificity. Bauman et al. [8] showed that every one unit increase in the score is associated with 50% increase in the ARDS risk with much higher cutoff value of 7 in surgical cohort of patients.
The enthusiasm associated with the use of biomarkers in clinical medicine had directed our attention to its use in predicting ARDS. Despite that a biomarker that is specifically involved in ARDS pathogenesis is expected to be more specific, we used the CRP which is in common clinical use in a variety of ICU conditions. The CRP-2 but not CRP-1 was found as a significant ARDS predictor in trauma and/or surgery patients with an AUC of 0.740. The CRP-2 of 57 mg/l was seen to be 76% sensitive and 67% specific. Zheng et al. [20] also identified the CRP as a predictor for ARDS occurrence in patients with trauma. The incorporation of CRP with other more specific predisposing conditions in one score was initially derived but needs to be validated [21] .
We reported a mortality rate of 38% with significantly higher mortality in patients with ARDS. More than 60% of patients with ARDS were nonsurvivors. Many studies showed mortality rates for ARDS in patients with trauma of 24% [1, 12, 22] and in postoperative patients to be between 15 and 45% [7, [23] [24] [25] . We postulated the higher mortality rates in our study to the enrollment of critically ill patients with APACHE-II more than or equal to 15. Salim et al. [26] identified the occurrence of ARDS as an independent mortality predictor in nontrauma surgical patients.We could not elucidate any relation between the studied LIPS and mortality. The CRP-2 was the only mortality predictor in our study. Contrary to these findings, Bauman et al. [8] found that the LIPS is a significant mortality predictor in surgical patients with 22% increase in the 30-day mortality for every unit increase in the score. Even in general ICU patients, Soto et al. [27] identified the LIPS as a mortality predictor. We found an AUC of 0.747 for CRP-2 to predict in-hospital mortality with a cutoff value of 94 mg/l to be 73% sensitive and 70% specific. Sharma et al. [28] identified the high CRP as a mortality predictor in ARDS, whereas Luecke et al. [29] found no relation between CRP and survival.
Irrelevant on the presence of ARDS, CRP was seen to be a mortality predictor in all spectrum of critically ill patients [30] .
The absence of some predisposing conditions for ARDS in the score items, such as the large volume of blood transfusion and fluids [31, 32] , might affect the score accuracy. Using those additional variables which are specifically important in the subsets of trauma and/ or surgery patients might improve the accuracy of these scoring systems. This will however affect the easy and fast nature of these scores.
Being a single-center study with small sample size is considered a limitation of this study. The enrollment of patients with higher APACHE-II scores who eventually have higher ARDS risk might explain the small sample size.
Conclusion
In conclusion, the LIPS that were validated in general hospitalized patients are shown to be significant predictors for ARDS in high-risk trauma and/or surgery ICU patients but with lower accuracy.
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